Sanofi Soars on Strong Q1 Profit; Citi Maintains Buy Rating
Sanofi Soars on Strong Q1 Profit; Sanofi, the French pharmaceutical giant, witnessed a significant surge in its stock price during pre-market trading on Thursday, April 25th, 2024. This positive movement came on the heels of the company releasing its first-quarter (Q1) financial results, which outperformed analyst expectations on a key profitability metric. This blog post … Read more